We came across a bullish thesis on AbbVie Inc. on Disruptive Analytics ’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on ABBV. AbbVie Inc.’s share was trading at $223.01 as of January 30th. ABBV’s trailing and forward P/E were 166.99 and 15.70 respectively according to Yahoo Finance.
RAJ CREATIONZS / shutterstock.com
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization,...
